Drw Securities, LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Drw Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$7.98 - $12.29 $239,400 - $368,700	-30,000 Reduced 19.95%	120,365 $1.48 Million
Q3 2020 Nov 12, 2020	BUY	$7.96 - $12.42 $318,400 - $496,800	40,000 Added 36.24%	150,365 $1.22 Million
Q3 2019 Nov 14, 2019	BUY	$9.59 - $12.0 $387,100 - $484,380	40,365 Added 57.66%	110,365 $1.13 Million
Q2 2019 Aug 14, 2019	BUY	$9.54 - $14.96 $667,799 - $1.05 Million	70,000 New	70,000 $742,000
Q1 2019 May 15, 2019	SELL	$10.31 - $14.38 $255,193 - $355,933	-24,752 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.63 - $12.4 $86,300 - $124,000	10,000 Added 67.79%	24,752 $251,000
Q3 2018 Nov 14, 2018	SELL	$9.6 - $12.9 $41,740 - $56,089	-4,348 Reduced 22.76%	14,752 $177,000
Q2 2018 Aug 14, 2018	BUY	$8.3 - $16.8 $25,730 - $52,080	3,100 Added 19.38%	19,100 $233,000
Q1 2018 May 14, 2018	BUY	$8.1 - $16.0 $129,600 - $256,000	16,000 New	16,000 $158,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Drw Securities, LLC with notifications on news.